Chao Chang

883 total citations
31 papers, 659 citations indexed

About

Chao Chang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Chao Chang has authored 31 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Chao Chang's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Chao Chang is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Chao Chang collaborates with scholars based in China, Taiwan and Vietnam. Chao Chang's co-authors include Qingwei Ji, Yingzhong Lin, Qiutang Zeng, Xuedong Wang, Shensheng Xiao, Lei Chen, Yang Fu, Xiaorong Liu, Jine Wu and Bangwei Wu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Experimental Cell Research.

In The Last Decade

Chao Chang

30 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chao Chang China 14 214 174 118 103 99 31 659
Gi Dong Han South Korea 18 106 0.5× 255 1.5× 53 0.4× 91 0.9× 32 0.3× 48 789
Shunhe Wang China 15 108 0.5× 385 2.2× 37 0.3× 101 1.0× 46 0.5× 31 762
Chih‐Yu Hsieh Taiwan 15 159 0.7× 303 1.7× 21 0.2× 84 0.8× 61 0.6× 32 761
Mayumi Matsumoto Japan 12 97 0.5× 253 1.5× 212 1.8× 47 0.5× 53 0.5× 38 941
Beihui He China 15 145 0.7× 351 2.0× 48 0.4× 34 0.3× 335 3.4× 43 863
Gabriela M. Sanda Romania 15 103 0.5× 276 1.6× 74 0.6× 51 0.5× 61 0.6× 26 637
Na Young Ko South Korea 15 236 1.1× 331 1.9× 35 0.3× 24 0.2× 66 0.7× 32 828
Hanis Hazeera Harith Malaysia 15 161 0.8× 259 1.5× 26 0.2× 30 0.3× 83 0.8× 34 655
Daryn R. Michael United Kingdom 16 483 2.3× 462 2.7× 67 0.6× 95 0.9× 158 1.6× 31 1.1k
Qing Wu China 16 143 0.7× 256 1.5× 51 0.4× 23 0.2× 65 0.7× 37 859

Countries citing papers authored by Chao Chang

Since Specialization
Citations

This map shows the geographic impact of Chao Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Chang more than expected).

Fields of papers citing papers by Chao Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Chang. The network helps show where Chao Chang may publish in the future.

Co-authorship network of co-authors of Chao Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Chang. A scholar is included among the top collaborators of Chao Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Chang. Chao Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhang, Yanghui, Bin Zhang, Penglei Chen, et al.. (2022). Early Initiation of Evolocumab Treatment in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Clinical Therapeutics. 44(6). 901–912. 11 indexed citations
4.
Zhang, Jianwei, Zicong Yang, Mengjie Wang, et al.. (2022). Secreted frizzled-related protein 4 exerts anti-atherosclerotic effects by reducing inflammation and oxidative stress. European Journal of Pharmacology. 923. 174901–174901. 15 indexed citations
5.
6.
Zhang, Jianwei, Zicong Yang, Mengjie Wang, et al.. (2021). Anti‐Interleukin‐16 Neutralizing Antibody Treatment Alleviates Sepsis‐Induced Cardiac Injury and Dysfunction via the Nuclear Factor Erythroid‐2 Related Factor 2 Pathway in Mice. Oxidative Medicine and Cellular Longevity. 2021(1). 6616422–6616422. 11 indexed citations
7.
Zhang, Jianwei, Zicong Yang, Changxing Hu, et al.. (2021). Anti‐Interleukin‐16‐Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin‐Treated Mice. Mediators of Inflammation. 2021(1). 6611085–6611085. 11 indexed citations
8.
Wu, Zhenhua, Jie Geng, Yunpeng Bai, et al.. (2021). MicroRNA-22 inhibition promotes the development of atherosclerosis via targeting interferon regulator factor 5. Experimental Cell Research. 409(2). 112922–112922. 11 indexed citations
9.
Chang, Chao, et al.. (2021). Combined glycoprotein IIb/IIIa inhibitor therapy with ticagrelor for patients with acute coronary syndrome. PLoS ONE. 16(2). e0246166–e0246166. 3 indexed citations
10.
Zhang, Zhiliang, et al.. (2021). The association between serum selenium concentration and prognosis in patients with heart failure in a Chinese population. Scientific Reports. 11(1). 14533–14533. 10 indexed citations
11.
Liu, Tianxiao, Jing Liu, Yingzhong Lin, et al.. (2019). IL-37 inhibits the maturation of dendritic cells through the IL-1R8-TLR4-NF-κB pathway. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1864(10). 1338–1349. 42 indexed citations
12.
Lu, Wan‐Jung, Chi‐Li Chung, Li Huang, et al.. (2018). An Antithrombotic Strategy by Targeting Phospholipase D in Human Platelets. Journal of Clinical Medicine. 7(11). 440–440. 5 indexed citations
13.
Liu, Wenjing, Chao Chang, Haiying Hu, & Hua Yang. (2018). Interleukin-23: A New Atherosclerosis Target. Journal of Interferon & Cytokine Research. 38(10). 440–444. 12 indexed citations
14.
15.
Chang, Chao, et al.. (2016). Protective Effect of Saccharomyces boulardii on Deoxynivalenol-Induced Injury of Porcine Macrophage via Attenuating p38 MAPK Signal Pathway. Applied Biochemistry and Biotechnology. 182(1). 411–427. 20 indexed citations
16.
Huang, Ying, Yingzhong Lin, Shumin Zhang, et al.. (2016). Circulating Omentin-1 Levels Are Decreased in Dilated Cardiomyopathy Patients with Overt Heart Failure. Disease Markers. 2016. 1–7. 19 indexed citations
17.
Chang, Chao, Qingwei Ji, Bangwei Wu, et al.. (2015). Chemerin15‐Ameliorated Cardiac Ischemia‐Reperfusion Injury Is Associated with the Induction of Alternatively Activated Macrophages. Mediators of Inflammation. 2015(1). 563951–563951. 26 indexed citations
18.
Wu, Bangwei, Kai Meng, Qingwei Ji, et al.. (2014). Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice. Clinical & Experimental Immunology. 176(3). 438–451. 100 indexed citations
19.
Chang, Chao, Wan‐Jung Lu, Thanasekaran Jayakumar, et al.. (2009). Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase. The Journal of Nutritional Biochemistry. 21(12). 1214–1221. 32 indexed citations
20.
Chang, Chao, et al.. (2008). Protective effect of epigallocatechin-3-gallate against myocardial ischemia and reperfusion injury in rats. Zhongguo jiceng yiyao. 15(8). 1309–1311. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gi Dong Han Breakdown of academic impact, for papers by Shunhe Wang Breakdown of academic impact, for papers by Chih‐Yu Hsieh Breakdown of academic impact, for papers by Mayumi Matsumoto Breakdown of academic impact, for papers by Beihui He Breakdown of academic impact, for papers by Gabriela M. Sanda Breakdown of academic impact, for papers by Na Young Ko Breakdown of academic impact, for papers by Hanis Hazeera Harith Breakdown of academic impact, for papers by Daryn R. Michael Breakdown of academic impact, for papers by Qing Wu
Rankless by CCL
2026